Dr Reddys to provide 2 percent royalty to DRDO on anti-COVID drug 2-DG sale in India Ruchika Sharma29 July 2021 12:42 PM ISTThe drug comes in powder form in sachet and is taken orally by dissolving it in water.
Torrent Pharma net profit rises 2.8 percent to Rs 330 crore in Q1 Ruchika Sharma28 July 2021 10:00 AM ISTNew Delhi: Drug firm Torrent Pharmaceuticals on Tuesday reported a 2.8 percent rise in its consolidated net profit to Rs 330 crore for the quarter...
BDR Pharma, DRDO collaborate for COVID drug 2-DG production Ruchika Sharma26 July 2021 1:00 PM ISTLast month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe...
COVID: Optimus Pharma submits phase 3 trials interim result for Molnupiravir capsules Ruchika Sharma22 July 2021 2:00 PM ISTOptimus has approached DCGI to seek Emergency Use Authorization for Molnupiravir in India, the release said.
Prosecution launched against Gautam Gambhir Foundation, 2 AAP MLAs in covid drugs case: Delhi Drugs Control Dept tells court Ruchika Sharma19 July 2021 11:30 AM ISTThe counsel for drug controller said that show cause notices have been issued to licensees under the Drugs and Cosmetics Act as well as those who were...
MSN Labs, DRDE ink pact for COVID drug 2-DG Ruchika Sharma10 July 2021 11:00 AM ISTNew Delhi: Drug firm MSN Laboratories on Friday said it has entered into a licence agreement with the Defence Research & Development Establishment...
Hetero announces interim clinical results of Molnupiravir in COVID patients in India Ruchika Sharma9 July 2021 2:31 PM ISTHyderabad: Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from...
DRDO grants license to Mankind Pharma for COVID drug 2-DG Farhat Nasim8 July 2021 5:47 PM ISTNew Delhi: Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to...
Fitch affirms Glenmark issuer default rating at BB with stable outlook Ruchika Sharma6 July 2021 12:30 PM ISTSingapore: Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.It said Glenmark's...
DRDO provides license to Laurus Labs for manufacturing COVID drug 2-DG Ruchika Sharma3 July 2021 1:26 PM ISTHyderabad: Hyderabad based Laurus Labs Limited has recently announced that the company has received the licence from Defence Research &...
Nosch Labs, CSIR-IICT ink pact for transfer of process knowhow to make anti-Covid drug 2-DG Ruchika Sharma29 Jun 2021 1:02 PM ISTHyderabad: CSIR-Indian Institute of Chemical Technology (IICT) and Nosch Labs have entered into a non-exclusive agreement for transfer of the process...
Shilpa Medicare secures DRDO nod for manufacturing anti-COVID drug 2DG Ruchika Sharma26 Jun 2021 12:09 PM ISTKarnataka: Shilpa Medicare Limited, has recently announced that the company has received an in-principle approval from Defence Research &...
